Daniel Abdun-Nabi, President & CEO at Emergent BioSolutions Inc. (EBS), sold 31,508 shares at $42.50 ($1.3M) on 2017-11-03, disclosed to the SEC on 2017-11-07.
Scheduled sale ($1.3M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.50 | 11,508 | $489K | 36.3% |
| 2 | $42.92 | 20,000 | $858K | 63.7% |
| Total | $42.77 avg | 31,508 | $1.3M | 100% |
| Filing → |
| EBS | SELL | 2018-09-18 | $1.9M | — | Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |